|
|
||||||||
1 Endocrinology Laboratory, Department of Biological Sciences, California State University at Long Beach, Long Beach, California 90840; and 2 Department of Pathology, 3 Division of Rheumatology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106
Nonresponsiveness to the
growth-stimulatory actions of insulin-like growth factor (IGF)-I in
chondrocytes has been reported in a number of disease states associated
with impaired glucose metabolism. Primary rabbit chondrocytes were
investigated for changes in their IGF response system [type-I IGF
receptor and IGF-binding protein (IGFBP) expression] and in their
ability to mount a synthetic response to IGF-I [as
35S-labeled proteoglycan
([35S]PG)
production] in media containing varying ambient glucose concentrations. Whereas basal
[35S]PG synthetic rate
was unaffected by glucose concentration, synthetic responsiveness to
IGF-I was lost in media containing <5 mmol/l glucose or in media
containing a "diabetic" glucose concentration (25 mmol/l). IGFBP
expression, as measured by Northern analysis of mRNA levels and Western
ligand blotting of secreted protein levels, was not significantly
altered in the different glucose media, nor were there any differences
in the cell surface localization of IGFBPs as assessed by affinity
cross-linking with 125I-labeled
IGF-I, suggesting that IGFBPs do not induce the IGF-I resistance. The
nonresponsiveness to IGF-I in reduced glucose occurred with
25-50% reductions in steady-state levels of IGF type-I receptor
mRNA and protein. A significant correlation between IGF receptor mRNA
level and synthetic response to IGF-I was observed between 0 and 10 mmol/l glucose concentrations, suggesting that the loss of
responsiveness in reduced glucose is manifested at the level of
transcription and/or receptor mRNA stability. In contrast,
nonresponsiveness to IGF-I in chondrocytes in diabetic glucose
concentrations occurred without changes in receptor mRNA and protein
levels, suggesting that IGF-I resistance was due to post-ligand-binding
receptor defects. It is proposed that IGF-I resistance in chondrocytes
subjected to inappropriate glucose levels may constitute an important
pathogenic mechanism in degenerative cartilage disorders.
insulin-like growth factor type I-receptor; insulin-like growth factor-binding protein; proteoglycan; cartilage
This article has been cited by other articles:
![]() |
A. R. Shikhman, D. C. Brinson, J. Valbracht, and M. K. Lotz Cytokine Regulation of Facilitated Glucose Transport in Human Articular Chondrocytes J. Immunol., December 15, 2001; 167(12): 7001 - 7008. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |